NLA Scientific Statement on Coronary Artery Calcium Scoring to Guide Preventive Strategies

A risk calculator estimates the probability that disease exists. A coronary calcium scan shows you whether it actually does. This National Lipid Association statement is a thorough case for using that direct look to settle the prevention decisions a calculator leaves ambiguous.

Its recommendations are refreshingly concrete and built around thresholds a patient can understand. A score of zero identifies a person at genuinely low short-term risk — low enough to justify deferring a statin in someone without diabetes, smoking, or a strong family history. A score of 100 or more argues for starting a statin regardless of what the calculator said. Higher scores — 300 to 1,000 and above — push toward high-intensity therapy and potentially add-on treatment, and a score above 100 also helps identify who might benefit from aspirin. The statement even addresses how often to repeat the scan, depending on the baseline result.

The power of the test, which the document emphasizes, is reclassification. CAC has the highest ability of any single biomarker to move patients out of the murky intermediate zone — confirming risk in some, safely de-escalating it in others, and thereby aiming treatment at the people who will actually benefit.

The honest caveat is that this is observational evidence, however strong. No randomized trial has yet shown that managing patients by CAC score improves outcomes versus not scanning — a gap that the parallel USPSTF statement weighs more conservatively.

We rate the evidence strong. For the central problem of efficient prevention — treating those who need it and sparing those who don’t — this is among the most directly useful documents in the library.